People
Matt Blaschke focuses on complex litigation involving scientific or technical issues, as well as general litigation. As a partner in our Environmental and Mass Tort and Toxic Tort practices, Matt represents energy, pharmaceutical, consumer product and chemical industry clients in state and federal courts throughout the country.
Matt’s experience ranges from large-scale multiparty litigation to individual product liability actions. He also advises clients on environmental laws and regulations, including the federal Insecticide, Fungicide and Rodenticide Act.
J.D., George Washington University, honors
B.A., Notre Dame
California
District of Columbia
U.S. District Court for the Central District of California
U.S. District Court for the Eastern District of California
U.S. District Court for the Northern District of California
U.S. District Court for the Southern District of California
December 7, 2022
King & Spalding Helps Get Thousands of Claims Dismissed in Zantac MDL
Currently representing a large energy company in mass tort litigation arising from facility fire in California.
Member of national coordinating team of lawyers representing GlaxoSmithKline (“GSK”) in product liability litigation throughout the country, including allegations that the antidepressant Paxil® causes congenital defects. Matt has prepared numerous cases for trial; deposed plaintiffs as well as third-party witnesses and treating physicians; developed and executed pretrial strategy; briefed dispositive and procedural motions; and coordinated discovery.
Defended GSK before Pennsylvania appellate courts following summary judgment for GSK in product liability litigation including allegations that Paxil® caused congenital defects.
See more
July 11, 2022
The Widening Circuit Split On State Court Climate Claims
December 7, 2022
King & Spalding Helps Get Thousands of Claims Dismissed in Zantac MDL
Currently representing a large energy company in mass tort litigation arising from facility fire in California.
Member of national coordinating team of lawyers representing GlaxoSmithKline (“GSK”) in product liability litigation throughout the country, including allegations that the antidepressant Paxil® causes congenital defects. Matt has prepared numerous cases for trial; deposed plaintiffs as well as third-party witnesses and treating physicians; developed and executed pretrial strategy; briefed dispositive and procedural motions; and coordinated discovery.
Defended GSK before Pennsylvania appellate courts following summary judgment for GSK in product liability litigation including allegations that Paxil® caused congenital defects.
See more
July 11, 2022
The Widening Circuit Split On State Court Climate Claims
December 7, 2022
King & Spalding Helps Get Thousands of Claims Dismissed in Zantac MDL
J.D., George Washington University, honors
B.A., Notre Dame
California
District of Columbia
U.S. District Court for the Central District of California
U.S. District Court for the Eastern District of California
U.S. District Court for the Northern District of California
U.S. District Court for the Southern District of California